Amphetamine - NDC Database
7 records found
Page:
66993-360 Sep 30, 2020
Amphetamine Extended-release Oral Suspension Extended-release Oral Suspension 1.25 mg/ml Oral Suspension, Extended Release by Prasco Laboratories
Amphetamine Extended-release Oral Suspension Extended-release Oral Suspension 1.25 mg/ml Oral Suspension, Extended Release by Prasco Laboratories
70165-005 Feb 16, 2016
Adzenys Xr-odt 3.1 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 3.1 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
70165-010 Feb 16, 2016
Adzenys Xr-odt 6.3 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 6.3 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
70165-015 Feb 16, 2016
Adzenys Xr-odt 9.4 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 9.4 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
70165-020 Feb 16, 2016
Adzenys Xr-odt 12.5 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 12.5 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
70165-025 Feb 16, 2016
Adzenys Xr-odt 15.7 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 15.7 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
70165-030 Feb 16, 2016
Adzenys Xr-odt 18.8 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Adzenys Xr-odt 18.8 mg Oral Tablet, Orally Disintegrating by Neos Therapeutics, Lp
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.